Off-pump lung re-transplantation avoiding clamshell thoracotomy is feasible and safe: a single-center experience

Abstract

Background Lung re-transplantation (re-LTx) is the only therapeutic option for selected patients with advanced allograft dysfunction. This study aims to describe our center’s experience to illustrate the feasibility and safety of off-pump re-LTx avoiding clamshell incision. Methods We performed a retrospective analysis of 42 patients who underwent bilateral re-LTx between 2007 and 2021. Patients were classified according to their surgical approach and extracorporeal life support (ECLS)-use. Demographics, surgical technique, and short- and long-term outcomes were compared between groups. Continuous data were examined with an independent-sample t -test or non-parametric test. Pearson’s chi-squared and Fisher’s exact were used to analyze categorical data. Results Twenty-six patients (61.9%) underwent re-LTx by anterior thoracotomy without ECLS. Compared to the more invasive approach (thoracotomy with ECLS and clamshell with/without ECLS, n=16, 38.1%), clamshell-avoiding off-pump re-LTx patients had a shorter operative time (471.6±111.2 vs. 704.0±273.4 min, P=0.010) and less frequent grade 3 primary graft dysfunction (PGD-3) at 72 h (7.7% vs. 37.5%, P=0.038). No significant difference was found in PGD-3 incidence within 72 h, mechanical ventilation, intensive care unit (ICU) and hospital stay, and the incidence of reoperation within 90 days between groups (P>0.05). In the long-term, the clamshell-avoiding and off-pump approach resulted in similar 1- and 5-year patient survival vs. the more invasive approach. Conclusions Our experience shows that clamshell-avoiding off-pump re-LTx is feasible and safe in selected patients on a case-by-case evaluation.

Complications related to extracorporeal life support in lung transplantation: single-center analysis

“…Off-pump LTx strategy requires not only proper hemodynamic and respiratory management with intra-operative re-assessment of ECLS need, but also a meticulous surgical approach ( 43 ). As previously reported by our group, it is feasible and safe to use this strategy even in patients undergoing re-transplantation ( 44 ). However, it remains essential to identify upfront patients that may strongly benefit from ECLS, such as PAH or patients with severe pulmonary hypertension related to their respiratory condition ( 9 ).…”